Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-24-000009

Chief Medical Officer acquired 17,530 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Podnos Yale Chief Medical Officer 2024-05-21 Grant or award +17,530 104,368 D
Derivatives
Podnos Yale Chief Medical Officer 2024-05-21 Grant or award · Non-Qualified Stock Option (right to buy) +43,825 43,825 D
Loading xslF345X05/edgardoc.xml…